← All organizations
Highest phase reached
Phase 2
First clinical trial
Jan 1, 2006Last known activity
May 25, 2010
Timeline
2000s
- Jan 1, 2002
Nevada Cancer Institute— Founded
Drugs by trial phase (10 distinct, 8 trials)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Recent trials (13)
- NCT01131247Overall official - principal investigatorPhase 2May 25, 2010
- NCT01131247Lead sponsorPhase 2May 25, 2010
- NCT01125787Overall official - principal investigatorPhase 2May 1, 2010
- NCT01125787Lead sponsorPhase 2May 1, 2010
- NCT00886457Lead sponsorPhase 1Apr 1, 2009
- NCT00701298Overall official - principal investigatorPhase 1Apr 1, 2009
- NCT00886457Overall official - principal investigatorPhase 1Apr 1, 2009
- NCT00880867Overall official - principal investigatorPhase 1Apr 1, 2009
- NCT00880867Lead sponsorPhase 1Apr 1, 2009
- NCT00498966Study chairPhase 2Jul 1, 2007
- NCT00354926Overall official - principal investigatorPhase 1Jul 1, 2006
- NCT00281125Lead sponsorPhase 1/Phase 2Jan 1, 2006
- NCT00281125Overall official - principal investigatorPhase 1/Phase 2Jan 1, 2006
Details
- Founded
- Summerlin, NV, US Jan 1, 2002
- Last known activity
- May 25, 2010